Because early Lyme disease often mimics other conditions and standard tests can miss initial infections, diagnosis is frequently delayed. A research team in New Hampshire now presents a molecular assay capable of identifying Borrelia burgdorferi with far greater precision, offering a promising path to faster treatment.
Read on